Opioid abuse and brain gene expression

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 331-349

  Przewlocki, Ryszard ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Gene expression; Opioid addiction; Opioid peptide; Opioid receptor; Transcription factor

Indexed keywords

CALCIUM ION; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MU OPIATE RECEPTOR; OPIATE; TRANSCRIPTION FACTOR AP 1;

BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; DOPAMINERGIC SYSTEM; GENE EXPRESSION; HUMAN; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; NARCOTICS; NEURONS; NEUROTRANSMITTER AGENTS; OPIOID PEPTIDES; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID;

EID: 4644220800     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.036     Document Type: Review

References (222)

1. C. Abbadie, Y. Pan, C.T. Drake, and G.W. Pasternak Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS Neuroscience 100 1 2000 141 153
2. E.E. Abdelhamid, and A.E. Takemori Characteristics of μ and β opioid binding sites in the striatal slices of morphinetolerant and-dependent mice Eur. J. Pharmacol. 198 1991 157 163
3. G.K. Aghajanian, and Y.Y. Wang Common alpha-2 and opiate effector mechanisms in locus coeruleus: intracellular studies in brain slices Neuropharmacology 26 1987 789 800
4. J. Alberola-Ila, and G. Hernandez-Hoyos The Ras/MAPK cascade and the control of positive selection Immunol. Rev. 191 2003 79 96
5. H. Ammer, and R. Schulz Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins Brain Res. 707 2 1996 235 244
6. H. Ammer, and R. Schulz Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gs alpha Mol. Pharmacol. 52 6 1997 993 999
7. S. Ammon, P. Mayer, U. Riechert, H. Tischmeyer, and V. Hollt Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal Brain Res. Mol. Brain. Res. 12 1-2 2003 113 125
8. C.N. Anderson, and A.M. Tolkovsky Role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside J. Neurosci. 19 2 1999 664 673
9. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J. Biol. Chem. 270 50 1995 29732 29738
10. M. Barrot, J.D. Olivier, L.I. Perrotti, R.J. DiLeone, O. Berton, A.J. Eisch, S. Impey, D.R. Storm, R.L. Neve, J.C. Yin, V. Zachariou, and E.J. Nestler CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli Proc. Natl. Acad. Sci. U. S. A. 99 17 2002 11435 11440
11. R. Basheer, and A. Tempel Morphine-induced reciprocal alterations in G alpha s and opioid peptide mRNA levels in discrete brain regions J. Neurosci. Res. 36 5 1993 551 557
12. M.L. Bayewitch, I. Nevo, T. Avidor-Reiss, R. Levy, W.F. Simonds, and Z. Vogel Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation Mol. Pharmacol. 57 4 2000 820 825
13. A. Becker, G. Grecksch, J. Kraus, B. Peters, H. Schroeder, S. Schulz, and V. Hollt Loss of locomotor sensitisation in response to morphine in D1 receptor deficient mice Naunyn-Schmiedeberg's Arch. Pharmacol. 363 5 2001 562 568
14. M.M. Belcheva, P.D. Haas, Y. Tan, V.M. Heaton, and C.J. Coscia The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells J. Pharmacol. Exp. Ther. 303 3 2002 909 918
15. D.M. Benbrook, and N.C. Jones Heterodimer formation between CREB and JUN proteins Oncogene 5 3 1990 295 302
16. M.T. Berhow, D.S. Russell, R.Z. Terwilliger, D. Beitner-Johnson, D.W. Self, R.M. Lindsay, and E.J. Nestler Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system Neuroscience 68 4 1995 969 979
17. M.A. Bernstein, and S.P. Welch Mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance Brain Res. Mol. Brain Res. 55 2 1998 237 242
18. A. Bertolini, R. Poggioli, and W. Fratta Withdrawal symptoms in morphine-dependent rats intracerebroventricularly injected with ACTH1-24 and with beta-MSH Life Sci. 29 3 1981 249 252
19. H.N. Bhargava, and A. Gulati Down-regulation of brain and spinal cord m-opiate receptors in morphine tolerant dependent rats Eur. J. Pharmacol. 190 1990 305 311
20. 3H][d-Pen2,d- Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats Eur. J. Pharmacol. 202 3 1991 403 408
21. W. Bilecki, and R. Przewlocki Effect of opioids on Ca2+/cAMP responsive element binding protein Acta Neurobiol. Exp. (Wars) 60 4 2000 557 567
22. W. Bilecki, A. Wawrzczak-Bargiela, and R. Przewlocki Activation of AP-1 and CRE-dependent gene expression J. Neurochem. 2004 (in press)
23. M.A. Bozarth Physical dependence produced by central morphine infusions: an anatomical mapping study Neurosci. Biobehav. Rev. 18 1994 373 383
24. M. Brandt, K. Fischer, L. Moroder, E. Wunsch, and B. Hamprecht Enkephalin evokes biochemical correlates of opiate tolerance and dependence in neuroblastomaxglioma hybrid cells FEBS Lett. 68 1 1976 38 40
25. D.M. Bronstein, K.A. Trujillo, and H. Akil Effects of morphine on endogenous opioid biosynthesis NIDA Res. Monogr. 90 1988 256 265
26. D.M. Bronstein, R. PrzewÅocki, and H. Akil Effects of morphine treatment on proopiomelanocortin systems in rat brain Brain Res. 519 1990 102 111
27. J.C. Buckingham Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides Neuroendocrinology 35 2 1982 111 116
28. N.T. Burford, L.M. Tolbert, and W. Sadee Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin 1 Eur. J. Pharmacol. 342 1998 123 126
29. X. Busquets, P. Ventayol, and J.A. Garcia-Sevilla Naloxone-precipitated withdrawal in morphine-dependent rats increases the expression of alpha 2a-adrenoceptor mRNA in brain Brain Res. Mol. Brain Res. 45 1 1997 154 158
30. B. Buzas, J. Rosenberger, and B.M. Cox Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist NeuroReport 7 1996 1505 1508
31. P. Cadet, K. Mantione, T.V. Bilfinger, and G.B. Stefano Morphine down regulates human vascular tissue estrogen receptor expression determined by real-time RT-PCR Neuroendocrinol. Lett. 23 2 2002 95 100
32. E. Cagetti, J. Liang, I. Spigelman, and R.W. Olsen Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors Mol. Pharmacol. 63 1 2003 53 64
33. S. Campeau, M.J. Miserendino, and M. Davis Intra-amygdalar infusion of the N-methyl-d-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus Behav. Neurosci. 106 1992 569 574
34. W.A. Carlezon Jr., M.S. Todtenkopf, D.L. McPhie, P. Pimentel, A.M. Pliakas, J.R. Stellar, and M. Trzcinska Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area Neuropsychopharmacology 25 2001 234 241
35. M.D. Cassell, and T.S. Gray Morphology of peptide-immunoreactive neurons in the rat central nucleus of the amygdala J. Comp. Neurol. 281 2 1989 320 333
36. S. Chakrabarti, P.Y. Law, and H.H. Loh Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine Brain Res. Mol. Brain Res. 30 2 1995 269 278
37. S. Chakrabarti, W. Yang, P.Y. Law, and H.H. Loh The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation Mol. Pharmacol. 52 1 1997 105 113
38. E.H. Chartoff, M. Papadopoulou, C. Konradi, and W.A. Carlezon Jr. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum J. Neurochem. 87 1 2003 107 118
39. Y. Chen, J. Liu, and L. Yu Functional coupling of a mu opioid receptor to G proteins and adenylyl cyclase: modulation by chronic morphine treatment Addict. Biol. 1 1 1996 49 59
40. Y. Chen, A. Mestek, J. Liu, and L. Yu Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors Biochem. J. 295 Pt 3 1993 625 628
41. Y. Chen, A. Mestek, J. Liu, J.A. Hurley, and L. Yu Molecular cloning and functional expression of a mu-opioid receptor from rat brain Mol. Pharmacol. 44 1 1993 8 12
42. H.O. Collier, and D.L. Francis Morphine abstinence is associated with increased brain cyclic AMP Nature 255 5504 1975 159 162
43. M. Connor, and M.J. Christie Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons J. Physiol. 509 Pt 1 1998 47 58
44. M. Connor, and G. Henderson Delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells Br. J. Pharmacol. 117 2 1996 333 340
45. P. Couceyro, and J. Douglass Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain Mol. Pharmacol. 47 1 1995 29 39
46. E. Coven, Y. Ni, K.L. Widnell, J. Chen, W.H. Walker, J.F. Habener, and E.J. Nestler Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity J. Neurochem. 71 5 1998 1865 1874
47. S.M. Crain, and K.F. Shen Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons Trends Pharmacol. Sci. 11 2 1990 77 81
48. C. Davidson, and J.A. Stamford Neurochemical evidence of functional A10 dopamine terminals innervating the ventromedial axis of the neostriatum in vitro voltammetric data in rat brain slices Brain Res. 615 1993 229 239
49. L.L. Devaud, F.D. Smith, D.R. Grayson, and A.L. Morrow Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis Mol. Pharmacol. 48 5 1995 861 868
50. L.L. Devaud, J.M. Fritschy, W. Sieghart, and A.L. Morrow Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal J. Neurochem. 69 1 1997 126 130
51. G. Di Chiara A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use J. Psychopharmacol. 12 1 1998 54 67
52. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 1988 5274 5278
53. R.S. Duman, J.F. Tallman, and E.J. Nestler Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus J. Pharmacol. Exp. Ther. 246 3 1988 1033 1039
54. S. Eitan, C.D. Bryant, N. Saliminejad, Y.C. Yang, E. Vojdani, D. Keith Jr., R. Polakiewicz, and C.J. Evans Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization J. Neurosci. 23 23 2003 8360 8369
55. R. El Kouhen, O.M. Kouhen, P.Y. Law, and H.H. Loh The absence of a direct correlation between the loss of [d-Ala2, MePhe4,Gly5-ol]Enkephalin inhibition of adenylyl cyclase activity and agonist-induced mu-opioid receptor phosphorylation J. Biol. Chem. 274 14 1999 9207 9215
56. J. Elliott, L. Guo, and J.R. Traynor Tolerance to mu-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[35S]-thio)triphosphate binding Br. J. Pharmacol. 121 7 1997 1422 1428
57. C.J. Evans, D.E. Keith Jr., H. Morrison, K. Magendzo, and R.H. Edwards Cloning of a delta opioid receptor by functional expression Science 258 5090 1992 1952 1955
58. J.H. Fallon, and F.M. Leslie Distribution of dynorphin and enkephalin peptides in the rat brain J. Comp. Neurol. 249 3 1986 293 336
59. X. Fan, J. Zhang, X. Zhang, W. Yue, and L. Ma Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain Neuropharmacology 43 5 2002 809 816
60. X.L. Fan, J.S. Zhang, X.Q. Zhang, and L. Ma Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain Neuroscience 122 4 2003 997 1002
61. M.S. Fannselow, and J.J. Kim Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist d,l-2-amino-5-phosphonovaleric acid to the basolateral amygdala Behav. Neurosci. 108 1994 210 212
62. W.M. Freeman, K. Brebner, W.J. Lynch, D.J. Robertson, D.C. Roberts, and K.E. Vrana Cocaine-responsive gene expression changes in rat hippocampus Neuroscience 108 3 2001 371 380
63. W.M. Freeman, M.A. Nader, S.H. Nader, D.J. Robertson, L. Gioia, S.M. Mitchell, J.B. Daunais, L.J. Porrino, D.P. Friedman, and K.E. Vrana Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression J. Neurochem. 77 2 2001 542 549
64. R.A. Fuchs, and R.E. See Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats Psychopharmacology (Berl.) 160 4 2002 425 433
65. K. Fukuda, S. Kato, K. Mori, M. Nishi, and H. Takeshima Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes FEBS Lett. 327 3 1993 311 314
66. M. Fukuda, I. Gotoh, Y. Gotoh, and E. Nishida Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal J. Biol. Chem. 271 33 1996 20024 20028
67. K. Fukunaga, and E. Miyamoto Role of MAP kinase in neurons Mol. Neurobiol. 16 1 1998 79 95
68. M.E. Fundytus, and T.J. Coderre Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence Br. J. Pharmacol. 113 4 1994 1215 1220
69. M.E. Fundytus, P.W. Schiller, M. Shapiro, G. Weltrowska, and T.J. Coderre Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi] Eur. J. Pharmacol. 286 1 1995 105 108
70. F. Georges, L. Stinus, B. Bloch, and C. Le Moine Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum Eur. J. Neurosci. 11 2 1999 481 490
71. C. Gianoulakis Endogenous opioids and addiction to alcohol and other drugs of abuse Curr. Top. Med. Chem. 4 1 2004 39 50
72. I. Gomes, J. Filipovska, and L.A. Devi Opioid receptor oligomerization. Detection and functional characterization of interacting receptors Methods Mol. Med. 84 2003 157 183
73. I. Gomes, A. Gupta, J. Filipovska, H.H. Szeto, J.E. Pintar, and L.A. Devi A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia Proc. Natl. Acad. Sci. U. S. A. 101 14 2004 5135 5139
74. S.S. Grewal, R.D. York, and P.J. Stork Extracellular-signal-regulated kinase signalling in neurons Curr. Opin. Neurobiol. 9 5 1999 544 553
75. D.A. Grueneberg, L. Pablo, K.Q. Hu, P. August, Z. Weng, and J. Papkoff A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway Mol. Cell. Biol. 23 11 2003 3936 3950
76. K.P. Gudehithlu, G.A. Tejwani, and H.N. Bhargava Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats Brain Res. 553 2 1991 284 290
77. X. Guitart, M.A. Thompson, C.K. Mirante, M.E. Greenberg, and E.J. Nestler Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus J. Neurochem. 58 3 1992 1168 1171
78. H.B. Gutstein, J.L. Thome, J.L. Fine, S.J. Watson, and H. Akil Pattern of c-fos mRNA induction in rat brain by acute morphine Can. J. Physiol. Pharm. 76 3 1998 294 303
79. A.T. Heikkila, O. Echenko, M. Uusi-Oukari, S.T. Sinkkonen, and E.R. Korpi Morphine withdrawal increases expression of GABA(A) receptor epsilon subunit mRNA in locus coeruleus neurons NeuroReport 12 13 2001 2981 2985
80. A. Herz Endogenous opioid systems and alcohol addiction Psychopharmacology (Berl.) 129 2 1997 99 111
81. A. Herz Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharm. 76 3 1998 252 258
82. J. Honkaniemi, M. Pelto-Huikko, L. Rechardt, J. Isola, A. Lammi, K. Fuxe, J.A. Gustafsson, A.C. Wikstrom, and T. Hokfelt Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus Neuroendocrinology 55 4 1992 451 459
83. S. Hu, W.S. Sheng, J.R. Lokensgard, and P.K. Peterson Morphine induces apoptosis of human microglia and neurons Neuropharmacology 42 6 2002 829 836
84. A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats Eur. J. Pharmacol. 283 1995 151 159
85. S. Impey, K. Obrietan, and D.R. Storm Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity Neuron 23 1 1999 11 14
86. S. Impey, K. Obrietan, S.T. Wong, S. Poser, S. Yano, G. Wayman, J.C. Deloulme, G. Chan, and D.R. Storm Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation Neuron 21 4 1998 869 883
87. E.H. Jacobs, S. Spijker, C.W. Verhoog, K. Kamprath, T.J. de Vries, A.B. Smit, and A.N. Schoffelmeer Active heroin administration induces specific genomic responses in the nucleus accumbens shell FASEB J. 16 14 2002 1961 1963
88. E.H. Jacobs, T.J. de Vries, A.B. Smit, and A.N. Schoffelmeer Gene transcripts selectively down-regulated in the shell of the nucleus accumbens long after heroin self-administration are up-regulated in the core independent of response contingency FASEB 18 1 2004 200 202
89. 3H]AMPA receptor binding and in situ hybridization of AMPA sensitive glutamate receptor A (GluR-A) subunits following morphine withdrawal in the rat brain Brain Res. Bull. 52 3 2000 217 221
90. W. Jin, N.M. Lee, H.H. Loh, and S.A. Thayer Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells J. Neurosci. 14 1994 1920 1929
91. S. Kaewsuk, P. Hutamekalin, A.J. Ketterman, N. Khotchabhakdi, P. Govitrapong, and S.O. Casalotti Morphine induces short-lived changes in G-protein gene expression in rat prefrontal cortex Eur. J. Pharmacol. 411 1-2 2001 11 16
92. B.L. Kieffer, K. Befort, C. Gaveriaux-Ruff, and C.G. Hirth The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization Proc. Natl. Acad. Sci. U. S. A. 89 24 1992 12048 12052
93. D.S. Kim, H.K. Lim, S. Jang, and S. Oh Changes of the level of G protein alpha-subunit mRNA by tolerance to and withdrawal from butorphanol Neurochem. Res. 28 12 2003 1771 1778
94. T. Koch, S. Schulz, H. Schroder, R. Wolf, E. Raulf, and V. Hollt Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization J. Biol. Chem. 273 13 1998 13652 13713
95. G.F. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13 1992 177 184
96. G.F. Koob, and M. Le Moal Drug abuse: hedonic homeostatic dysregulation Science 278 5335 1997 52 58
97. G.F. Koob, and E.J. Nestler The neurobiology of drug addiction J. Neuropsychiatry Clin. Neurosci. 9 3 1997 482 497
98. G.F. Koob, and N.R. Swerdlow The functional output of the mesolimbic dopamine system Ann. N.Y. Acad. Sci. 537 1988 216 227
99. G.F. Koob, A.J. Roberts, G. Schulteis, L.H. Parsons, C.J. Heyser, P. Hyytia, E. Merlo-Pich, and F. Weiss Neurocircuitry targets in ethanol reward and dependence Alcohol Clin. Exp. Res. 22 1 1998 3 9
100. C. Kornetsky, and L.J. Porrino Brain mechanisms of drug-induced reinforcement Res. Publ. - Assoc. Res. Nerv. Ment. Dis. 70 1992 59 77
101. H.K. Kramer, and E.J. Simon Mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization Neuropharmacology 39 10 2000 1707 1719
102. M.L. Laorden, M.V. Milanes, E. Angel, P. Tankosic, and A. Burlet Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study J. Neuroendocrinol. 15 6 2003 586 591
103. S.R. Laviolette, R.A. Gallegos, S.J. Henriksen, and D. van der Kooy Opiate state controls bi-directional reward signaling via GABAA receptors in the ventral tegmental area Nat. Neurosci. 7 2 2004 160 169
104. P.Y. Law, and H.H. Loh Regulation of opioid receptor activities J. Pharmacol. Exp. Ther. 289 2 1999 607 624
105. C.Q. Lee, Y.D. Yun, rJ.P. Hoeffle, and J.F. Habener Cyclic-AMP-responsive transcriptional activation of CREB-327 involves interdependent phosphorylated subdomains EMBO J. 9 13 1990 4455 4465
106. S. Li, J. Zhu, C. Chen, Y.W. Chen, J.K Deriel, B. Ashby, and L.Y. Liu-Chen Molecular cloning and expression of a rat kappa opioid receptor Biochem. J. 295 Pt 3 1993 629 633
107. J. Liu, J. Nickolenko, and F.R. Sharp Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-d-aspartate receptors Proc. Natl. Acad. Sci. U. S. A. 91 18 1994 8537 8541
108. A.V. Loguinov, L.M. Anderson, G.J. Crosby, and R.Y. Yukhananov Gene expression following acute morphine administration Physiol. Genomics 6 3 2001 169 181
109. J. Ma, N. Ye, N. Lange, and B.M. Cohen Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus Neuroscience 121 4 2003 991 998
110. W. Ma, W.H. Zheng, K. Powell, K. Jhamandas, and R. Quirion Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study Eur. J. Neurosci. 14 7 2001 1091 1094
111. S.A. Mackler, and J.H. Eberwine Cellular adaptation to opiates alters ion-channel mRNA levels Proc. Natl. Acad. Sci. U. S. A. 91 1 1994 385 389
112. S.D. Mahajan, S.A. Schwartz, T.C. Shanahan, R.P. Chawda, and M.P. Nair Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor J. Immunol. 169 7 2002 3589 3599
113. M. Maj, J. Turchan, M. Smialowska, and B. Przewlocka Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala Neuropeptides 37 2 2003 105 110
114. R. Maldonado, J.A. Blendy, E. Tzavara, P. Gass, B.P. Roques, J. Hanoune, and G. Schutz Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB Science 273 5275 1996 657 659
115. R. Maldonado, S. Negus, and G.F. Koob Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists Neuropharmacology 31 12 1992 1231 1241
116. R. Maldonado, A. Saiardi, O. Valverde, T.A. Samad, B.P. Roques, and E. Borrelli Absence of opiate rewarding effects in mice lacking dopamine D2 receptors Nature 388 6642 1997 586 589
117. T. Mamiya, Y. Noda, X. Ren, M. Hamdy, S. Furukawa, T. Kameyama, K. Yamada, and T. Nabeshima Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor Br. J. Pharmacol. 132 5 2001 1111 1117
118. A. Mansour, C.A. Fox, S. Burke, F. Meng, R.C. Thompson, H. Akil, and S.J. Watson Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study J. Comp. Neurol. 350 3 1994 412 438
119. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson Anatomy of CNS opioid receptors Trends Neurosci. 11 7 1988 308 314
120. J. Mao, B. Sung, R.R. Ji, and G. Lim Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism J. Neurosci. 22 17 2002 7650 7661
121. G. Martin, S.H. Ahmed, T. Blank, J. Spiess, G.F. Koob, and G.R. Siggins Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens J. Neurosci. 19 1999 9081 9089
122. N. Matus-Leibovitch, V. Ezra-Macabee, D. Saya, B. Attali, T. Avidor-Reiss, J. Barg, and Z. Vogel Increased expression of synapsin I mRNA in defined areas of the rat central nervous system following chronic morphine treatment Brain Res. Mol. Brain Res. 34 2 1995 221 230
123. N. Matus-Leibovitch, I. Nevo, and Z. Vogel Differential distribution of synapsin IIa and IIb mRNAs in various brain structures and the effect of chronic morphine administration on the regional expression of these isoforms Brain Res. Mol. Brain Res. 45 2 1997 301 316
124. C. Mazzucchelli, C. Vantaggiato, A. Ciamei, S. Fasano, P. Pakhotin, W. Krezel, H. Welzl, D.P. Wolfer, G. Pages, O. Valverde, A. Marowsky, A. Porrazzo, and P.C. Orban Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory Neuron 34 5 2002 807 820
125. P. Maye, H. Rochlitz, E. Rauch, H. Rommelspacher, H.E. Hasse, S. Schmidt, and V. Hollt Association between a delta opioid receptor gene polymorphism and heroin dependence in man NeuroReport 8 1997 2547 2550
126. G.P. McNally, and H. Akil Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal Neuroscience 112 3 2002 605 617
127. A.K. Mehta, and M.K. Ticku An update on GABAA receptors Brain Res. Brain Res. Rev. 29 2-3 1999 196 217
128. F. Meng, G.X. Xie, R.C. Thompson, A. Mansour, A. Goldstein, S.J. Watson, and H. Akil Cloning and pharmacological characterization of a rat kappa opioid receptor Proc. Natl. Acad. Sci. U. S. A. 90 21 1993 9954 9958
129. K. Menkens, E.J. Bilsky, K.D. Wild, P.S. Portoghese, L.D. Reid, and F. Porreca Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole Eur. J. Pharmacol. 219 1992 345 346
130. A. Mestek, J.H. Hurley, L.S. Bye, A.D. Campbell, Y. Chen, M. Tian, J. Liu, H. Schulman, and L. Yu The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C J. Neurosci. 15 3Pt 2 1995 2396 2406
131. T.E. Meyer, and J.F. Habener Cyclic adenosine 3′,5′- monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins Endocr. Rev. 14 3 1993 269 290
132. M.V. Milanes, M.L. Laorden, M. Chapleur-Chateau, and A. Burlet Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response Naunyn-Schmiedeberg's Arch. Pharmacol. 356 5 1997 603 610
133. M. Minami, T. Toya, Y. Katao, K. Maekawa, S. Nakamura, T. Onogi, S. Kaneko, and M. Satoh Cloning and expression of a cDNA for the rat kappa-opioid receptor FEBS Lett. 329 3 1993 291 295
134. I. Mocchetti, A. Ritter, and E. Costa Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats J. Mol. Neurosci. 1 1 1989 33 38
135. D.L. Muller, and E.M. Unterwald In vivo regulation of ERK and Akt phosphorylation by acute and chronic morphine J. Pharmacol. Exp. Ther. 310 2 2004 774 782
136. T. Nakagawa, M. Minami, and M. Satoh Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu receptor Eur. J. Pharmacol. 433 1 2001 29 36
137. M. Narita, M. Makimura, Y. Feng, B. Hoskins, and I.K. Ho Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance Brain Res. 650 1 1994 175 179
138. M. Narita, M. Ioka, M. Suzuki, M. Narita, and T. Suzuki Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain Neurosci. Lett. 324 2 2002 97 100
139. E.J. Nestler Molecular mechanisms of drug addiction J. Neurosci. 12 7 1992 2439 2450
140. E.J. Nestler Cellular responses to chronic treatment with drugs of abuse Crit. Rev. Neurobiol. 7 1 1993 23 39
141. E.J. Nestler Genes and addiction Nat. Genet. 26 3 2000 277 281
142. E.J. Nestler Psychogenomics: opportunities for understanding addiction J. Neurosci. 21 21 2001 8324 8327
143. E.J. Nestler, and G.K. Aghajanian Molecular and cellular basis of addiction Science 278 5335 1997 58 63
144. K.E. Nikolarakis, A. Pfeiffer, G.K. Stalla, and A. Herz Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways Brain Res. 498 2 1989 385 388
145. S. Niu, C.H. Kuo, Y. Gan, E. Nishikawa, T. Sadakata, H. Ichikawa, and N. Miki Increase of calmodulin III gene expression by mu-opioid receptor stimulation in PC12 cells Jpn. J. Pharmacol. 84 4 2000 412 417
146. M. Nishi, H. Takeshima, K. Fukuda, S. Kato, and K. Mori cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands FEBS Lett. 330 1 1993 77 80
147. H.E. Nye, and E.J. Nestler Induction of chronic Fos-related antigens in rat brain by chronic morphine administration Mol. Pharmacol. 49 4 1996 636 645
148. J. Ortiz, H.W. Harris, X. Guitart, R.Z. Terwilliger, J.W. Haycock, and E.J. Nestler Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine J. Neurosci. 15 2 1995 1285 1297
149. T. Ozawa, T. Nakagawa, K. Shige, M. Minami, and M. Satoh Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal Brain Res. 905 1-2 2001 254 258
150. D. Parolaro, T. Rubino, E. Gori, P. Massi, C. Bendotti, G. Patrini, C. Marcozzi, and M. Parenti In situ hybridization reveals specific increases in G alpha s and G alpha o mRNA in discrete brain regions of morphine-tolerant rats Eur. J. Pharmacol. 244 3 1993 211 222
151. G.W. Pasternak, and Y.X. Pan Antisense mapping: assessing functional significance of genes and splice variants Methods Enzymol. 314 2000 51 60
152. M.B. Patel, C.N. Patel, V. Rajashekara, and B.C. Yoburn Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo Mol. Pharmacol. 62 6 2002 1464 1470
153. R.N. Pechnick Effects of opioids on the hypothalamo-pituitary-adrenal axis Annu. Rev. Pharmacol. Toxicol. 33 1993 353 382
154. T.P. Piepponen, A. Honkanen, T. Kivastik, A. Zharkovsky, A. Turtia, J.A. Mikkola, and L. Ahtee Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission Pharmacol. Biochem. Behav. 63 2 1999 245 252
155. B. Przewlocka, W. Lason, and R. Przewlocki The effect of chronic morphine and cocaine on Gs and Go protein messenger RNA levels in the rat hippocampus Neuroscience 63 1994 1111 1116
156. B. Przewlocka, J. Turchan, W. Lason, and R. Przewlocki The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat Neuroscience 70 3 1996 749 754
157. B. Przewlocka, J. Turchan, W. Lason, and R. Przewlocki Ethanol withdrawal enhances prodynorphin system activity in the rat nucleus accumbens Neurosci. Lett. 238 1997 13 16
158. R. Przewlocki, K.L. Parsons, D.D. Sweeney, C. Trotter, J.G. Netzeband, G.R. Siggins, and D.L. Gruol Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons J. Neurosci. 19 22 1999 9705 9715
159. S. Pu, H. Zhuang, Z. Lu, X. Wu, and J. Ha Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance Brain Res. Mol. Brain Res. 21 3-4 1994 183 189
160. L.J. Punch, D.W. Self, E.J. Nestler, and J.R. Taylor Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray J. Neurosci. 17 21 1997 8520 8527
161. T. Ramarao, and H.N. Bhargava Effect of thyrotropin releasing hormone on the development of tolerance to the analgesic and hyperthermic actions of morphine in the rat Neuropeptides 15 1990 213 217
162. A.K. Rattan, K.L. Koo, G.A. Tejwani, and H.N. Bhargava The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat Brain Res. 584 1-2 1992 207 212
163. 3H]naltrexone to discrete brain regions and spinal cord of the rat Gen. Pharmacol. 25 2 1994 355 361
164. J.P. Richards, H.P. Bachinger, R.H. Goodman, and R.G. Brennan Analysis of the structural properties of cAMP-responsive element-binding protein (CREB) and phosphorylated CREB J. Biol. Chem. 271 23 1996 13716 13723
165. J.M. Rodriguez Parkitna, W. Bilecki, P. Mierzejewski, R. Stefanski, A. Ligeza, A. Bargiela, B. Ziolkowska, W. Kostowski, and R. Przewlocki Differential gene expression in rat amygdala after morphine self-administration J. Neurochem. 2004 (in press)
166. R.B. Rothman, L.S. Brady, H. Xu, and J.B. Long Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro- Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain Peptides 14 6 1993 1271 1277
167. T. Rubino, M. Parenti, G. Patrini, P. Massi, and D. Parolaro Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous system Eur. J. Neurosci. 7 11 1995 2334 2340
168. H.H. Samson, and R.A. Harris Neurobiology of alcohol abuse Trends Pharmacol. Sci. 13 5 1992 206 211
169. P. Sanchez-Blazquez, A. Garcia-Espana, and J. Garzon Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors J. Pharmacol. Exp. Ther. 280 1997 1423 1431
170. M. Satoh, W. Zieglgansberger, and A. Herz Actions of opiates upon single unit activity in the cortex of naive and tolerant rats Brain Res. 115 1 1976 99 110
171. H. Schmidt, S. Schulz, M. Klutzny, T. Koch, M. Handel, and V. Hollt Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells J. Neurochem. 74 1 2000 414 422
172. J. Sepulveda, P. Oliva, and E. Contreras Neurochemical changes of the extracellular concentrations of glutamate and aspartate in the nucleus accumbens of rats after chronic administration of morphine Eur. J. Pharmacol. 483 2-3 2004 249 258
173. S.K. Sharma, M. Nirenberg, and W.A. Klee Morphine receptors as regulators of adenylate cyclase activity Proc Natl. Acad. Sci. U. S. A. 72 2 1975 590 594
174. T.Z. Shaw-Lutchman, M. Barrot, T. Wallace, L. Gilden, V. Zachariou, S. Impey, R.S. Duman, D. Storm, and E.J. Nestler Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal J. Neurosci. 22 9 2002 3663 3672
175. M. Sheng, M.A. Thompson, and M.E. Greenberg CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases Science 252 5011 1991 1427 1430
176. A. Shimomura, Y. Okamoto, Y. Hirata, M. Kobayashi, K. Kawakami, K. Kiuchi, T. Wakabayashi, and M. Hagiwara Dominant negative ATF1 blocks cyclic AMP-induced neurite outgrowth in PC12D cells J. Neurochem. 70 3 1998 1029 1034
177. T.S. Shippenberg, R. Bals-Kubik, and A. Herz Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors J. Pharmacol. Exp. Ther. 265 1 1993 53 59
178. L.J. Sim, D.E. Selley, R. Xiao, and S.R. Childers Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum Eur. J. Pharmacol. 307 1 1996 97 105
179. G.R Siggins, G. Martin, M. Roberto, Z. Nie, S. Madamba, and L. De Lecea Glutamatergic transmission in opiate and alcohol dependence Ann. N.Y. Acad. Sci. 1003 2003 196 211
180. D. Smart, and D.G. Lambert The stimulatory effects of opioids and their possible role in the development of tolerance Trends Pharmacol. Sci. 17 7 1996 264 269
181. D. Smart, and D.G. Lambert Delta-Opioids stimulate inositol 1,4,5-trisphosphate formation, and so mobilize Ca2+ from intracellular stores, in undifferentiated NG108-15 cells J. Neurochem. 66 4 1996 1462 1467
182. S.H. Snyder, and G.W. Pasternak Historical review: opioid receptors Trends Pharmacol. Sci. 24 4 2003 198 205
183. D.D. Song, and R.E. Harlan The development of enkephalin and substance P neurons in the basal ganglia: insights into neostriatal compartments and the extended amygdala Brain Res. Dev. Brain Res. 83 2 1994 247 261
184. R. Spangler, A. Ho, Y. Zhou, C.E. Maggos, V. Yuferov, and M.J. Kreek Regulation of kappa opioid receptor mRNA in the rat brain binge pattern cocaine administration and correlation with preprodynorphin mRNA Mol. Brain Res. 19 1996 323 327
185. S. Spijker, S.W. Houtzager, M.C. De Gunst, W.P. De Boer, A.N. Schoffelmeer, and A.B. Smit Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens FASEB J. 18 7 2004 848 850
186. L. Stanfa, A. Dickenson, X-J. Xu, and Z. Wiesenfeld-Hallin Cholecystokinin and morphine analgesia: variations on a theme TIPS 15 1994 65 66
187. J.I. Szekely, E. Miglecz, Z. Dunai-Kovacs, I. Tarnawa, A.Z. Ronai, L. Graf, and S. Bajusz Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone(alpha-MSH) Life Sci. 24 21 1979 1931 1938
188. K. Starowicz, A. Sieja, W. Bilecki, I. Obara, and B. Przewlocka The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade Brain Res. 990 1-2 2003 113 119
189. T. Suzuki, M. Tsuji, T. Mori, M. Misawa, and H. Nagase Involvement of α1 and β2 opioid receptor subtypes in the development of physical dependence on morphine in mice Pharmacol. Biochem. Behav. 57 1997 293 299
190. S. Suzuki, M.P. Carlos, L.F. Chuang, J.V. Torres, R.H. Doi, and R.Y. Chuang Methadone induces CCR5 and promotes AIDS virus infection FEBS Lett. 519 1-3 2002 173 177 (Epub 2002 May 22)
191. T. Tang, B.A. Stevens, and B.M. Cox Opioid regulation of intracellular free calcium in cultured mouse dorsal root ganglion neurons J. Neurosci. Res. 44 4 1996 338 343
192. P.-L. Tao, P.-Y. Law, and H.H. Loh Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment J. Pharmacol. Exp. Ther. 240 1987 809 816
193. P.L. Tao, L.R. Chang, P.Y. Law, and H.H. Loh Decrease in delta-opioid receptor density in rat brain after chronic [d-Ala2,d-Leu5]enkephalin treatment Brain Res. 462 1988 313 320
194. R.Z. Terwilliger, D. Beitner-Johnson, K.A. Sevarino, S.M. Crain, and E.J. Nestler A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function Brain Res. 548 1-2 1991 100 110
195. G.H. Tjon, P. Voorn, L.J. Vanderschuren, T.J. de Vries, N.H. Michiels, A.J. Jonker, H. Klop, P. Nestby, A.H. Mulder, and A.N. Schoffelmeer Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration Neuroscience 76 1 1997 67 76
196. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 4989 1991 85 87
197. K.A. Trujillo, D.M. Bronstein, I.O. Sanchez, and H. Akil Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides Brain Res. 698 1-2 1995 69 78
198. J. Turchan, W. Lason, B. Budziszewska, and B. Przewlocka Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain Neuropeptides 31 1 1997 24 28
199. J. Turchan, B. Przewlocka, W. Lason, and R. Przewlocki Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain Neuroscience 85 1998 1051 1059
200. J. Turchan, B. Przewlocka, G. Toth, W. Lason, A. Borsodi, and R. Przewlocki The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat Neuroscience 91 1999 971 977
201. J. Turchan, M. Maj, B. Przewlocka, and R. Przewlocki Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system Pol. J. Pharmacol. 54 4 2002 367 372
202. J. Turchan, M. Maj, and B. Przewlocka The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system Drug Alcohol Depend. 72 2 2003 193 196
203. H. Ueda, T. Miyamae, N. Fukushima, H. Takeshima, K. Fukuda, Y. Sasaki, and Y. Misu Opioid mu- and kappa-receptor mediate phospholipase C activation through Gi1 in Xenopus oocytes Brain Res. Mol. Brain Res. 32 1995 166 170
204. G.R. Uhl, J.P. Ryan, and J.P. Schwartz Morphine alters preproenkephalin gene expression Brain Res. 459 2 1988 391 397
205. G.R. Uhl, I. Sora, and Z. Wang The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses Proc. Natl. Acad. Sci. U. S. A. 96 14 1999 7752 7755
206. E. Valjent, C. Pages, D. Herve, J.A. Girault, and J. Caboche Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain Eur. J. Neurosci. 19 7 2004 1826 1836
207. E.J. Van Bockstael, J. Peoples, A.S. Menko, K. McHugh, and G. Drolet Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment J. Neurosci. 20 23 2000 8659 8666
208. B.J. Van Vliet, S.R. Ruuls, B. Drukarch, A.H. Mulder, and A.N. Schoffelmeer Beta-adrenoceptor-sensitive adenylate cyclase is inhibited by activation of mu-opioid receptors in rat striatal neurons Eur. J. Pharmacol. 195 2 1991 295 300
209. J.M. Van Ree, R.J. Niesink, L. Van Wolfswinkel, N.F. Ramsey, M.M. Kornet, W.R. Van Furth, L.J. Vanderschuren, M.A. Gerrits, and C.L. Van den Berg Endogenous opioids and reward Eur. J. Pharmacol. 405 1-3 2000 89 101
210. G. Waeber, and J.F. Habene Nuclear translocation and DNA recognition signals colocalized within the bZIP domain of cyclic adenosine 3′,5′-monophosphate response element-binding protein CREB Mol. Endocrinol. 5 10 1991 1431 1438
211. Z. Wang, and W. Sadee Dissociation of morphine-induced cyclic AMP-upregulation and mu-opioid receptor desensitization Proc. West Pharmacol. Soc. 43 2000 9 10
212. X.M. Wang, Y. Zhou, R. Spangler, A. Ho, J.S. Han, and M.J. Kreek Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain Brain Res. Mol. Brain Res. 66 1-2 1999 184 187
213. K.L. Widnell, D.S. Russell, and E.J. Nestler Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro Proc. Natl. Acad. Sci. U. S. A. 91 23 1994 10947 10951
214. K.L. Widnell, J.S. Chen, P.A. Iredale, W.H. Walke, R.S. Duman, J.F. Habener, and E.J. Nestler Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells J. Neurochem. 66 4 1996 1770 1773
215. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol. Rev. 94 4 1987 469 492
216. P.L. Wood, and T.S. Rao Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels Neuropharmacology 30 4 1991 399 401
217. G.X. Xie, S.A. Fuller, and E.A. Stein Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study J. Pharmacol. Exp. Ther. 284 1 1998 151 161
218. N. Yabaluri, and F. Medzihradsky Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling Mol. Pharmacol. 52 5 1997 896 902
219. V. Yuferov, T. Kroslak, K.S. Laforge, Y. Zhou, A. Ho, and M.J. Kreek Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis Synapse 48 4 2003 157 169
220. W. Zhou, H. Liu, and X. Xie The expression of glial cell derived neurotrophic factor and its receptor GDNFR-alpha and GDNFR-beta mRNA in spinal cord, brainstem and frontal cortex during morphine withdrawal in rats Zhonghua Yixue Zazhi 80 2 2000 135 139
221. H. Zhu, and G.A. Barr Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent Synapse 40 4 2001 282 293
222. H. Zhu, and I.K. Ho NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine Eur. J. Pharmacol. 352 2-3 1998 151 156